Putting cholesterol in its place: apoE and reverse cholesterol transport.

To avoid toxic overload of cholesterol in peripheral cells, the reverse cholesterol transport pathway directs excess cholesterol through HDL acceptors to the liver for elimination. In this issue of the JCI, a study by Matsuura et al. reveals new features of this pathway, including the importance of the ATP-binding cassette transporter G1 in macrophages and apoE in cholesteryl efflux from cells to cholesterol ester-rich (CE-rich) HDL(2) acceptors (see the related article beginning on page 1435). One proposal for boosting reverse cholesterol transport has been to elevate plasma HDL levels by inhibiting CE transfer protein (CETP), which transfers CE from HDL to lower-density lipoproteins. However, there has been concern that large, CE-rich HDL(2) generated by CETP inhibition might impair reverse cholesterol transport. ApoE uniquely facilitates reverse cholesterol transport by allowing CE-rich core expansion in HDL. In lower species, these large HDLs are not atherogenic. Thus, CETP might not be essential for reverse cholesterol transport in humans, raising hope of using a CETP inhibitor to elevate HDL levels.

[1]  R. Mahley,et al.  Characterization of the lipoproteins of atherosclerotic swine. , 1977, The Journal of biological chemistry.

[2]  M. Krieger.  Charting the fate of the "good cholesterol": identification and characterization of the high-density lipoprotein receptor SR-BI. , 1999, Annual review of biochemistry.

[3]  A. von Eckardstein,et al.  Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL. , 1996, Biochimica et biophysica acta.

[4]  O. Francone,et al.  Increased prebeta-HDL levels, cholesterol efflux, and LCAT-mediated esterification in mice expressing the human cholesteryl ester transfer protein (CETP) and human apolipoprotein A-I (apoA-I) transgenes. , 1996, Journal of lipid research.

[5]  Davidson Ws,et al.  Apolipoprotein structural organization in high density lipoproteins: belts, bundles, hinges and hairpins. , 2005 .

[6]  R. Mahley,et al.  Subfractionation of human high density lipoproteins by heparin-Sepharose affinity chromatography. , 1980, Journal of lipid research.

[7]  P. Barter,et al.  Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species. , 1982, Comparative biochemistry and physiology. B, Comparative biochemistry.

[8]  R. Mahley,et al.  Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. , 1975, Biochemistry.

[9]  R. Mahley,et al.  Plasma lipoproteins: apolipoprotein structure and function. , 1984, Journal of lipid research.

[10]  G. Marinetti.  Disorders of Lipid Metabolism , 1990, Springer US.

[11]  H. Suzuki,et al.  A low prevalence of coronary heart disease among subjects with increased high-density lipoprotein cholesterol levels, including those with plasma cholesteryl ester transfer protein deficiency. , 1998, Preventive medicine.

[12]  S. Yamashita,et al.  Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. , 1990, The Journal of clinical investigation.

[13]  R. Mahley,et al.  Obligatory role of cholesterol and apolipoprotein E in the formation of large cholesterol-enriched and receptor-active high density lipoproteins. , 1985, Journal of Biological Chemistry.

[14]  Y. Marcel,et al.  Biochemical and physical properties of remnant-HDL2 and of pre beta 1-HDL produced by hepatic lipase. , 1999, Biochemistry.

[15]  J. Oram.  Tangier disease and ABCA1. , 2000, Biochimica et biophysica acta.

[16]  A. Tall,et al.  1999 George Lyman Duff memorial lecture: lipid transfer proteins, HDL metabolism, and atherogenesis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[17]  D. Rader,et al.  New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport , 2005, Circulation research.

[18]  R. Mahley,et al.  Interaction of canine and swine lipoproteins with the low density lipoprotein receptor of fibroblasts as correlated with heparin/manganese precipitability. , 1977, The Journal of biological chemistry.

[19]  A. Tall,et al.  A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly Published, JLR Papers in Press, February 16, 2004. DOI 10.1194/jlr.M300520-JLR200 , 2004, Journal of Lipid Research.

[20]  R. Mahley,et al.  Formation of cholesterol- and apoprotein E-enriched high density lipoproteins in vitro. , 1983, The Journal of biological chemistry.

[21]  R. Mahley,et al.  Modulating Effects of Canine High Density Lipoproteins on Cholesteryl Ester Synthesis Induced by B‐Very Low Density Lipoproteins in Macrophages: Possible In Vitro Correlates with Atherosclerosis , 1982, Arteriosclerosis.

[22]  B. Perret,et al.  Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. , 1994, The Journal of biological chemistry.

[23]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[24]  A. Tall,et al.  HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. , 2006, The Journal of clinical investigation.

[25]  R. Mahley,et al.  Structural organization of the lipoprotein HDLc from atherosclerotic swine. Structural features relating the particle surface and core. , 1978, Biochemistry.

[26]  S. Yokoyama.  Assembly of high density lipoprotein by the ABCA1/apolipoprotein pathway. , 2005, Current opinion in lipidology.

[27]  R. Mahley.  Atherogenic lipoproteins and coronary artery disease: concepts derived from recent advances in cellular and molecular biology. , 1985, Circulation.

[28]  A. van Tol,et al.  Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects. , 2001, Scandinavian journal of clinical and laboratory investigation.

[29]  R. Mahley,et al.  ALTERATIONS IN HUMAN HIGH-DENSITY LIPOPROTEINS, WITH OR WITHOUT INCREASED PLASMA-CHOLESTEROL, INDUCED BY DIETS HIGH IN CHOLESTEROL , 1978, The Lancet.

[30]  R. Williams,et al.  Williams Textbook of endocrinology , 1985 .

[31]  K. Weisgraber,et al.  Model of Biologically Active Apolipoprotein E Bound to Dipalmitoylphosphatidylcholine* , 2006, Journal of Biological Chemistry.

[32]  P. Linsel-Nitschke,et al.  HDL as a target in the treatment of atherosclerotic cardiovascular disease , 2005, Nature Reviews Drug Discovery.